Tresckow, B. v., Fanale, M., Ardeshna, K. M., Chen, R. W., Meißner, J., Morschhauser, F., . . . Brice, P. (2019). Patient-reported outcomes in KEYNOTE-087, a phase 2 study of pembrolizumab in patients with classical Hodgkin lymphoma. Leukemia and lymphoma, 60(11), . https://doi.org/10.1080/10428194.2019.1602262
Chicago-Zitierstil (17. Ausg.)Tresckow, Bastian von, et al. "Patient-reported Outcomes in KEYNOTE-087, a Phase 2 Study of Pembrolizumab in Patients with Classical Hodgkin Lymphoma." Leukemia and Lymphoma 60, no. 11 (2019). https://doi.org/10.1080/10428194.2019.1602262.
MLA-Zitierstil (9. Ausg.)Tresckow, Bastian von, et al. "Patient-reported Outcomes in KEYNOTE-087, a Phase 2 Study of Pembrolizumab in Patients with Classical Hodgkin Lymphoma." Leukemia and Lymphoma, vol. 60, no. 11, 2019, https://doi.org/10.1080/10428194.2019.1602262.